Literature DB >> 28183198

Doxorubicin-resistant osteosarcoma: novel therapeutic approaches in sight?

Claudia M Hattinger1, Marilù Fanelli1, Elisa Tavanti1, Serena Vella1, Chiara Riganti2, Piero Picci1, Massimo Serra1.   

Abstract

Entities:  

Keywords:  doxorubicin; drug resistance; osteosarcoma

Mesh：

Substances：

Year:  2017        PMID： 28183198     DOI： 10.2217/fon-2016-0519

Source DB:  PubMed          Journal:  Future Oncol        ISSN： 1479-6694            Impact factor:   3.404


× No keyword cloud information.
  13 in total

1.  Triptonide Modulates MAPK Signaling Pathways and Exerts Anticancer Effects via ER Stress-Mediated Apoptosis Induction in Human Osteosarcoma Cells.

Authors:  Liyun Zheng; Shiji Fang; Junguo Hui; Vinothkumar Rajamanickam; Minjiang Chen; Qiaoyou Weng; Xulu Wu; Zhongwei Zhao; Jiansong Ji
Journal:  Cancer Manag Res       Date:  2020-07-17       Impact factor: 3.989

2.  Alginate Oligosaccharide DP5 Exhibits Antitumor Effects in Osteosarcoma Patients following Surgery.

Authors:  Jiayu Chen; Yu Hu; Lirong Zhang; Yingjian Wang; Shichao Wang; Yanzi Zhang; Haiyan Guo; Degang Ji; Yingtao Wang
Journal:  Front Pharmacol       Date:  2017-09-12       Impact factor: 5.810

3.  Small Nucleolar RNAs Determine Resistance to Doxorubicin in Human Osteosarcoma.

Authors:  Martina Godel; Deborah Morena; Preeta Ananthanarayanan; Ilaria Buondonno; Giulio Ferrero; Claudia M Hattinger; Federica Di Nicolantonio; Massimo Serra; Riccardo Taulli; Francesca Cordero; Chiara Riganti; Joanna Kopecka
Journal:  Int J Mol Sci       Date:  2020-06-24       Impact factor: 5.923

4.  Functionalized Keratin as Nanotechnology-Based Drug Delivery System for the Pharmacological Treatment of Osteosarcoma.

Authors:  Elisa Martella; Claudia Ferroni; Andrea Guerrini; Marco Ballestri; Marta Columbaro; Spartaco Santi; Giovanna Sotgiu; Massimo Serra; Davide Maria Donati; Enrico Lucarelli; Greta Varchi; Serena Duchi
Journal:  Int J Mol Sci       Date:  2018-11-20       Impact factor: 5.923

5.  Mitochondria-targeting graphene oxide nanocomposites for fluorescence imaging-guided synergistic phototherapy of drug-resistant osteosarcoma.

Authors:  Wei-Nan Zeng; Qiu-Ping Yu; Duan Wang; Jun-Li Liu; Qing-Jun Yang; Zong-Ke Zhou; Yi-Ping Zeng
Journal:  J Nanobiotechnology       Date:  2021-03-19       Impact factor: 10.435

6.  Exosomal Long Non-Coding RNA ANCR Mediates Drug Resistance in Osteosarcoma.

Authors:  Xin Hu; Yang Wen; Lin-Yun Tan; Jie Wang; Fan Tang; Yi-Tian Wang; Chuan-Xi Zheng; Yu-Qi Zhang; Tao-Jun Gong; Li Min
Journal:  Front Oncol       Date:  2022-01-12       Impact factor: 6.244

Review 7.  Recent Advances in the Treatment of Bone Metastases and Primary Bone Tumors: An Up-to-Date Review.

Authors:  Adrian Emilian Bădilă; Dragoș Mihai Rădulescu; Adelina-Gabriela Niculescu; Alexandru Mihai Grumezescu; Marius Rădulescu; Adrian Radu Rădulescu
Journal:  Cancers (Basel)       Date:  2021-08-23       Impact factor: 6.639

8.  Development of a Nomogram for Predicting the Efficacy of Preoperative Chemotherapy in Osteosarcoma.

Authors:  Qingshan Huang; Chenglong Chen; Jingbing Lou; Yi Huang; Tingting Ren; Wei Guo
Journal:  Int J Gen Med       Date:  2021-08-26

9.  Notoginsenoside R1 counteracts mesenchymal stem cell-evoked oncogenesis and doxorubicin resistance in osteosarcoma cells by blocking IL-6 secretion-induced JAK2/STAT3 signaling.

Authors:  Minan Lu; Kegong Xie; Xianzhe Lu; Lu Lu; Yu Shi; Yujin Tang
Journal:  Invest New Drugs       Date:  2020-10-30       Impact factor: 3.850

Review 10.  Novel molecular insights and new therapeutic strategies in osteosarcoma.

Authors:  Babak Otoukesh; Bahram Boddouhi; Mehdi Moghtadaei; Peyman Kaghazian; Maria Kaghazian
Journal:  Cancer Cell Int       Date:  2018-10-16       Impact factor: 5.722
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.